Anti-apoptotic NF-κB and "Gain of Function" mutp53 in concert act pro-apoptotic in response to UVB+IL-1 via enhanced TNF production

Journal of Investigative Dermatology

Volumn 135, Issue 3, 2015, Pages 851-860

  Müller, Ines ^a   Beissert, Stefan ^a   Kulms, Dagmar ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALYCULIN A; CASPASE 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; I KAPPA B ALPHA; INTERLEUKIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL DENSITY; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA DAMAGE; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET B RADIATION; UPREGULATION; ADVERSE EFFECTS; CELL LINE; CFU COUNTING; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RADIATION RESPONSE; ULTRAVIOLET RADIATION;

APOPTOSIS; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; COLONY-FORMING UNITS ASSAY; DNA DAMAGE; HUMANS; INTERLEUKIN-1; KERATINOCYTES; NF-KAPPA B; PHOSPHORYLATION; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 84922667828     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.481     Document Type: Article

References (55)

1. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6:203-8
2. Almeida LO, Abrahao AC, Rosselli-Murai LK et al. (2014) NFkappaB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC) FEBS Open Bio 4:96-104
3. Barisic S, Schmidt C, Walczak H et al. (2010) Tyrosine phosphatase inhibition triggers sustained canonical serine-dependent NFkappaB activation via Src-dependent blockade of PP2A. Biochem Pharmacol 80:439-47
4. Barisic S, Strozyk E, Peters N et al. (2008) Identification of PP2A as a crucial regulator of the NF-kappaB feedback loop: its inhibition by UVB turns NF-kappaB into a pro-Apoptotic factor. Cell Death Differ 15:1681-90
5. Bohuslav J, Chen LF, Kwon H et al. (2004) p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem 279:26115-25
6. Campbell KJ, Rocha S, Perkins ND (2004) Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 13:853-65
7. Delhase M, Hayakawa M, Chen Y et al. (1999) Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284:309-13
8. Deppert W (2007) Mutant p53: from guardian to fallen angel? Oncogene 26:2142-4
9. Feldmeyer L, Keller M, Niklaus G et al. (2007) The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 17:1140-5
10. Friedrich MW, Aramuni G, Mank M et al. (2010) Imaging CREB activation in living cells. J Biol Chem 285:23285-95
11. Fujioka S, Son K, Onda S et al. (2012) Desensitization of NFkappaB for overcoming chemoresistance of pancreatic cancer cells to TNF-Alpha or paclitaxel. Anticancer Res 32:4813-21
12. Fusenig NE, Boukamp P, Breitkreutz D et al. (1990) In vitro transformation of human skin epithelial cells: role of RAS oncogene in malignant progression. Toxicol In Vitro 4:627-34
13. Gervin CM, McCulla A, Williams M et al. (2003) Dysfunction of p53 in photocarcinogenesis. Front Biosci 8:s715-7
14. Goehler T, Jaeger S, Warnecke G et al. (2005) Mutant p53 proteins bind DNA in a DNA structure-selective mode. Nucleic Acids Res 33: 1087-100
15. Graham B, Gibson SB (2005) The two faces of NFkappaB in cell survival responses. Cell Cycle 4:1342-5
16. Gurzov EN, Germano CM, Cunha DA et al. (2010) p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic beta-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. J Biol Chem 285:19910-20
17. Hoffmann A, Levchenko A, Scott ML et al. (2002) The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298:1241-5
18. Huang WC, Ju TK, Hung MC et al. (2007) Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell 26:75-87
19. Ikeda A, Sun X, Li Y et al. (2000) p300/CBP-dependent and-independent transcriptional interference between NF-kappaB RelA and p53. Biochem Biophys Res Commun 272:375-9
20. Kawauchi K, Araki K, Tobiume K et al. (2008) Activated p53 induces NFkappaB DNA binding but suppresses its transcriptional activation. Biochem Biophys Res Commun 372:137-41
21. Kim E, Deppert W (2007) Interactions of mutant p53 with DNA: guilt by association. Oncogene 26:2185-90
22. Klein AM, Brash DE, Jones PH et al. (2010) Stochastic fate of p53-mutant epidermal progenitor cells is tilted toward proliferation by UV B during preneoplasia. Proc Natl Acad Sci USA 107:270-5
23. Konrath F, Witt J, Sauter T et al. (2014) Identification of new IkappaBalpha complexes by an iterative experimental and mathematical modeling approach. PLoS Comput Biol 10:e1003528
24. Kulms D, Schwarz T (2000) Molecular mechanisms of UV-induced apoptosis. Photodermatol Photoimmunol Photomed 16:195-201
25. Kuo CT, Leiden JM (1999) Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol 17:149-87
26. Lehman TA, Modali R, Boukamp P et al. (1993) p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14:833-9
27. Lin A, Karin M (2003) NF-kappaB in cancer: a marked target. Semin Cancer Biol 13:107-14
28. Liu J, Yang D, Minemoto Y et al. (2006) NF-kappaB is required for UV-induced JNK activation via induction of PKCdelta. Mol Cell 21:467-80
29. Ma S, Tang J, Feng J et al. (2008) Induction of p21 by p65 in p53 null cells treated with Doxorubicin. Biochim Biophys Acta 1783:935-40
30. Mello SS, Attardi LD (2013) Not all p53 gain-of-function mutants are created equal. Cell Death Differ 20:855-7
31. Moll UM, Wolff S, Speidel D et al. (2005) Transcription-independent proapoptotic functions of p53. Curr Opin Cell Biol 17:631-6
32. Muller PA, Vousden KH (2013) p53 mutations in cancer. Nat Cell Biol 15: 2-8
33. Murphy G, Young AR, Wulf HC et al. (2001) The molecular determinants of sunburn cell formation. Exp Dermatol 10:155-60
34. Narayanan A, Amaya M, Voss K et al. (2014) Reactive oxygen species activate NFkappaB (p65) and p53 and induce apoptosis in RVFV infected liver cells. Virology 449:270-86
35. O'Prey J, Crighton D, Martin AG et al. (2010) p53-mediated induction of Noxa and p53AIP1 requires NFkappaB. Cell Cycle 9:947-52
36. Poppelmann B, Klimmek K, Strozyk E et al. (2005) NFkB-dependent downregulation of tumor necrosis factor receptor-Associated proteins contributes to interleukin-1-mediated enhancement of ultraviolet B-induced apoptosis. J Biol Chem 280:15635-43
37. Ray D, Murphy KR, Gal S (2012) The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation. Cancer Biol Ther 13:848-57
38. Ryan KM, Ernst MK, Rice NR et al. (2000) Role of NF-kappaB in p53-mediated programmed cell death. Nature 404:892-7
39. Schneider G, Henrich A, Greiner G et al. (2010) Cross talk between stimulated NF-kappaB and the tumor suppressor p53. Oncogene 29: 2795-806
40. Seitz SJ, Schleithoff ES, Koch A et al. (2010) Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway. Int J Cancer 126:2049-66
41. Soussi T, Wiman KG (2007) Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 12:303-12
42. Spooren A, Kooijman R, Lintermans B et al. (2010) Cooperation of NFkappaB and CREB to induce synergistic IL-6 expression in astrocytes. Cell Signal 22:871-81
43. Strozyk E, Poppelmann B, Schwarz T et al. (2006) Differential effects of NF-kappaB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome. Oncogene 25:6239-51
44. Szoltysek K, Pietranek K, Kalinowska-Herok M et al. (2008) TNFalpha-induced activation of NFkappaB protects against UV-induced apoptosis specifically in p53-proficient cells. Acta Biochim Pol 55:741-8
45. Tergaonkar V (2009) p53 and NFkappaB: fresh breath in the cross talk. Cell Res 19:1313-5
46. Tergaonkar V, Pando M, Vafa O et al. (2002) p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell 1:493-503
47. Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8:275-83
48. Wang P, Qiu W, Dudgeon C et al. (2009) PUMA is directly activated by NF-kappaB and contributes to TNF-Alpha-induced apoptosis. Cell Death Differ 16:1192-202
49. Webster GA, Perkins ND (1999) Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol 19:3485-95
50. Weisz L, Damalas A, Liontos M et al. (2007) Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells. Cancer Res 67:2396-401
51. Witt J, Barisic S, Schumann E et al. (2009) Mechanism of PP2A-mediated IKKbeta dephosphorylation: a systems biological approach. BMC Syst Biol 3:71
52. Yarosh DB, Kripke ML (1996) DNA repair and cytokines in antimutagenesis and anticarcinogenesis. Mutat Res 350:255-60
53. Zalcenstein A, Stambolsky P, Weisz L et al. (2003) Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumorassociated p53 mutants. Oncogene 22:5667-76
54. Zhang XP, Liu F, Wang W (2011) Two-phase dynamics of p53 in the DNA damage response. Proc Natl Acad Sci USA 108:8990-5
55. Zschiedrich I, Hardeland U, Krones-Herzig A et al. (2008) Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression. Blood 112:264-76